- Report
- March 2024
- 191 Pages
Global
From €3226EUR$3,374USD£2,765GBP
€3585EUR$3,749USD£3,072GBP
- Report
- January 2024
- 150 Pages
Global
From €4638EUR$4,850USD£3,974GBP
- Report
- February 2024
- 182 Pages
Global
From €4686EUR$4,900USD£4,015GBP
- Report
- February 2024
- 184 Pages
Global
From €3442EUR$3,600USD£2,950GBP
- Report
- February 2024
- 132 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- May 2021
- 87 Pages
Global
€21037EUR$22,000USD£18,027GBP
- Report
- June 2019
Global
From €7172EUR$7,500USD£6,146GBP
- Report
- September 2019
Global
From €5135EUR$5,370USD£4,400GBP
- Report
- February 2024
- 180 Pages
Global
From €5258EUR$5,499USD£4,506GBP
€2785EUR$3,120USD£2,470GBP
The Endocrine Disease market is a subset of Endocrinology, which is the study of hormones and their effects on the body. Endocrine diseases are conditions that affect the production, release, transport, and action of hormones. These diseases can be caused by genetic or environmental factors, and can affect the body's metabolism, growth, and development. Endocrine diseases can be divided into two categories: primary endocrine diseases, which are caused by a malfunction of the endocrine glands, and secondary endocrine diseases, which are caused by other diseases or conditions.
Common endocrine diseases include diabetes, thyroid disorders, and adrenal disorders. Treatment for endocrine diseases typically involves lifestyle changes, medications, and/or surgery.
Companies in the Endocrine Disease market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more